Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

P311 Inhibitors

Chemical inhibitors of P311 can exert their inhibitory effects through various mechanisms by targeting specific signaling pathways and enzymes that are associated with the functional activity of P311. Wortmannin and LY294002 are inhibitors of phosphoinositide 3-kinases (PI3K), a key component of the Akt signaling pathway. The Akt pathway plays a critical role in cell migration and wound healing processes in which P311 is known to be involved. By inhibiting PI3K, these chemicals effectively reduce Akt activation, leading to a functional inhibition of P311's role in these cellular processes. Similarly, Rapamycin targets the mTOR complex, another integral part of the PI3K/Akt pathway, which influences P311 activity. The inhibition of mTOR by Rapamycin results in a downstream reduction of P311's involvement in the related cellular functions.

Additionally, several chemicals act on the MAPK/ERK and JNK pathways, which are also associated with P311's role in cellular dynamics. PD98059 and U0126 are specific inhibitors of MEK, a kinase that is necessary for the activation of the ERK pathway. By inhibiting MEK, these chemicals decrease ERK activation, and consequently, the activity of P311 in promoting cell migration is reduced. SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which can regulate cell migration and repair processes involving P311. SB203580, which inhibits p38 MAPK, targets the stress response functions of P311. Inhibition of this kinase leads to reduced P311 activity in stress-related cellular responses. The Src family kinase inhibitor PP2, the ROCK inhibitor Y-27632, and the EGFR inhibitors Gefitinib and Erlotinib all act on upstream regulators or signaling molecules that influence the pathway cascades in which P311 is active. By inhibiting these regulators, the respective chemicals decrease the activation of pathways that are critical to P311's functions. Lastly, Sorafenib, a multi-kinase inhibitor, targets receptors involved in the MAPK pathway, leading to a direct reduction in the functional processes associated with P311.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$85.00
$132.00
$287.00
$495.00
$3752.00
42
(0)

Erlotinib is another inhibitor of EGFR tyrosine kinase, which can influence signaling pathways associated with P311 function. Inhibition of EGFR by Erlotinib would diminish the activity of pathways where P311 is involved.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Sorafenib is a kinase inhibitor that targets multiple receptors, including those involved in the MAPK pathway, which is related to P311 function. Inhibition of these kinases by Sorafenib can lead to functional inhibition of P311-associated processes.